Stock Rating Upgrade The Value Trend Rating for Acme United Corp (NYSEAMERICAN: ACU) rose significantly of late from C to A reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included […]
Cryo-Cell International Inc (NYSEAMERICAN: CCEL) stock enjoyed a major increase of 10.7% on 3/7/24. The shares closed at $6.10. Moreover, exceptionally high trading volume at 331% of normal accompanied the advance. Relative to the market […]
Acme United Corp (NYSEAMERICAN: ACU) has reported earnings for its fourth fiscal quarter (ending December 31) of $3.10 versus a loss $-0.17 for the same period a year ago. For the latest four quarters through […]
Stock Rating Upgrade The Value Trend Rating for National Healthcare Corp (NYSEAMERICAN: NHC) improved recently from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our […]
CompX International Inc. (NYSEAMERICAN: CIX) stock enjoyed a major increase of 19.2% on 3/4/24. The shares closed at $27.77. Moreover, exceptionally high trading volume at 237% of normal accompanied the advance. Relative to the market […]
inTest Corp (NYSEAMERICAN: INTT) has reported E.P.S. of $0.14 for its fourth fiscal quarter (ending December 31) versus $0.30 for the same period a year ago — a decline of -53%. Relative to the consensus […]
On 2/29/24, Adams Resources & Energy Inc. (NYSEAMERICAN: AE) stock enjoyed a major increase of 11.5%, closing at $29.89. Moreover, exceptionally high trading volume at 335% of normal accompanied the advance. The stock has risen […]
Intellinetics Inc (NYSEAMERICAN: INLX) stock closed at $8.35 on 2/26/24 after a major increase of 15.2%. Moreover, trading volume in this advance was exceptionally high at 572% of normal. The stock has risen 27.9% during […]
On 2/26/24, Palatin Technologies Inc. (NYSEAMERICAN: PTN) stock enjoyed a major increase of 15.7%, closing at $3.62. Moreover, this advance was accompanied by unusually high trading volume at 178% of normal. Relative to the market […]
On 2/26/24, Actinium Pharmaceuticals Inc (NYSEAMERICAN: ATNM) stock enjoyed a major increase of 21.1%, closing at $8.31. Moreover, trading volume in this advance was exceptionally high at 324% of normal. Relative to the market the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research